ETI can efficiently restore CFTR function in CF bronchial epithelial cells from donors with eligible mutations; ETI attenuates lipid dysregulation, such as an increased fatty acid ratio, and oxidative stress in CF bronchial epithelial cell cultures (Veltman et al., 2021). This evidence concerns the gene CFTR and cystic fibrosis.